Jean Temeck
Impact in
-
- Pharmaceutical studies and practices
- Pediatric Pain Management Techniques
- Statistics and Probability top 10%
- Statistical Methods in Clinical Trials
Papers in
-
- Pharmaceutical studies and practices 7
- Ethics and Legal Issues in Pediatric Healthcare 2
-
- Health Systems, Economic Evaluations, Quality of Life 3
- Pharmaceutical Economics and Policy 2
- Co-authors
- Dianne Murphy (4 shared papers)Haihao Sun (4 shared papers)P. Tomasi (2 shared papers)Wiley Chambers (2 shared papers)John R. Johnson (2 shared papers)C W Boone (1 shared paper)Gary J. Kelloff (2 shared papers)James A. Crowell (2 shared papers)
- Journals
- Therapeutic Innovation & Regulatory Science (4 papers)JAMA Pediatrics (2 papers)Journal of Cellular Biochemistry (1 paper)JAMA Ophthalmology (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesNetherlands
In The Last Decade
Jean Temeck
10 papers receiving 258 citations
Peers
Comparison fields: 5 of 65
- Pediatrics, Perinatology and Child Health 119
- Statistics and Probability 25
- Speech and Hearing 19
- Psychiatry and Mental health 35
- Cancer Research 29
Countries citing papers authored by Jean Temeck
This map shows the geographic impact of Jean Temeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Temeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Temeck more than expected).
Fields of papers citing papers by Jean Temeck
This network shows the impact of papers produced by Jean Temeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Temeck. The network helps show where Jean Temeck may publish in the future.
Co-authors
The 25 scholars most cited alongside Jean Temeck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Approaches to the development and marketing approval of drugs that prevent cancer. | 1995 | 85 |
| 2 | 2017 | 49 | |
| 3 | 2017 | 49 | |
| 4 | 2013 | 40 | |
| 5 | 2018 | 14 | |
| 6 | 2016 | 8 | |
| 7 | 1994 | 7 | |
| 8 | 2018 | 5 | |
| 9 | 2020 | 5 | |
| 10 | 2021 | 4 |
About Jean Temeck
Jean Temeck is a scholar working on Pediatrics, Perinatology and Child Health, Economics and Econometrics, Statistics and Probability, Cancer Research and Pathology and Forensic Medicine, having authored 10 papers that have together received 266 indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (7 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Ethics and Legal Issues in Pediatric Healthcare (2 papers), Pharmaceutical Economics and Policy (2 papers), Statistical Methods in Clinical Trials (2 papers), Attention Deficit Hyperactivity Disorder (1 paper), Cancer Treatment and Pharmacology (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Pediatrics, Perinatology and Child Health (119 citations), Statistics and Probability (25 citations), Speech and Hearing (19 citations), Psychiatry and Mental health (35 citations) and Cancer Research (29 citations). Jean Temeck has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Dianne Murphy, Haihao Sun, P. Tomasi, Wiley Chambers, John R. Johnson, C W Boone, Gary J. Kelloff, James A. Crowell, W Schmidt and Gerard Burke. Their work appears in journals such as Therapeutic Innovation & Regulatory Science, JAMA Pediatrics, Journal of Cellular Biochemistry, JAMA Ophthalmology and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.